Attached files
file | filename |
---|---|
10-K - FORM 10-K - QUESTCOR PHARMACEUTICALS INC | f55254e10vk.htm |
EX-32 - EX-32 - QUESTCOR PHARMACEUTICALS INC | f55254exv32.htm |
EX-31 - EX-31 - QUESTCOR PHARMACEUTICALS INC | f55254exv31.htm |
EX-10.85 - EX-10.85 - QUESTCOR PHARMACEUTICALS INC | f55254exv10w85.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos.
333-134879, 333-114166, 333-102988, 333-85160, 333-61866, 333-25661, 333-32159, 333-23085,
333-17501, 333-03507, and 333-107755) and the Registration Statements on Form S-8 (Nos. 333-116624,
333-30558, 333-46990, 333-81243, 333-105694, 333-105693, 333-134878, and 333-151395), pertaining to
the 1992 Stock Option Plan, the 1993 Non-Employee Directors Equity Incentive Plan, the 2000
Employee Stock Purchase Plan, the 2003 Employee Stock Purchase Plan, the 2004 Non-Employee
Directors Equity Incentive Plan and the 2006 Equity Incentive Award Plan of Questcor
Pharmaceuticals, Inc. of our reports dated March 15, 2010, with respect to the consolidated
financial statements and schedule of Questcor Pharmaceuticals, Inc. and the effectiveness of
internal control over financial reporting of Questcor Pharmaceuticals, Inc. included in this Annual
Report on Form 10-K for the year ended December 31, 2009.
/s/ ODENBERG, ULLAKKO, MURANISHI & CO. LLP
San Francisco, California
DATE March 15, 2010
San Francisco, California
DATE March 15, 2010